Results 131 to 140 of about 492,235 (272)

Amyloidosis in juvenile rheumatoid arthritis [PDF]

open access: yesArthritis & Rheumatism, 1978
O, García-Morteo   +2 more
openaire   +2 more sources

Acute Pustular Facial Eruption in a 5‐Year‐Old Boy

open access: yes
Pediatric Dermatology, EarlyView.
Naia Oillarburu   +4 more
wiley   +1 more source

The Impact of Caring for a Child With Juvenile Idiopathic Arthritis on Caregiver Quality of Life

open access: yesACR Open Rheumatology, Volume 8, Issue 10, October 2026.
Objective Juvenile idiopathic arthritis (JIA) impacts children and their families, often increasing caregiver burden and diminishing quality of life. This study assessed the care‐related quality of life of parent‐caregivers of children with JIA using the Care‐Related Quality of Life instrument (CarerQol), identified the most affected caregiving ...
Deborah A. Marshall   +105 more
wiley   +1 more source

Work Productivity Loss and Activity Impairment in Parents of Children With Juvenile Idiopathic Arthritis

open access: yesACR Open Rheumatology, Volume 8, Issue 10, October 2026.
Objective To determine the impact of juvenile idiopathic arthritis (JIA) on work productivity loss and daily activities of parents. Methods The multicenter Canada‐Netherlands Understanding Childhood Arthritis Network (UCAN) CAN‐DU and CURE study captures consecutive clinical and patient‐reported data for patients and parents since 2019.
Deborah A. Marshall   +109 more
wiley   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao   +5 more
wiley   +1 more source

Drug‐Induced Liver Injury During Treatment With Tocilizumab: A Case Report of an Atypical Pattern Lesion

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
ABSTRACT Tocilizumab is an interleukin‐6 (IL‐6) receptor antagonist indicated for various rheumatologic conditions. While hepatotoxicity is a recognized adverse effect, it predominantly manifests as hepatocellular injury. We report a rare case of drug‐induced liver injury (DILI) presenting with a cholestatic pattern and cholangitis features in a 75 ...
Louis‐Edmond Barbaro   +7 more
wiley   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

open access: yesArthritis Care &Research, Volume 78, Issue 9, Page 1195-1200, September 2026.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya   +4 more
wiley   +1 more source

Patient Perspectives and Expectations on the Use of Artificial Intelligence to Guide Treatment Decision‐Making in Juvenile Idiopathic Arthritis: A Qualitative Study

open access: yesACR Open Rheumatology, Volume 8, Issue 9, September 2026.
Objective Artificial intelligence (AI) is rapidly transforming clinical decision‐making. However, patient perspectives on these technologies remain understudied in pediatric care. We investigated patient and parent perspectives on AI use in juvenile idiopathic arthritis (JIA) care among a highly engaged cohort.
Mei‐Sing Ong   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy